Haemonetics (HAE)
NYSE:HAE
Haemonetics (HAE) Ownership Overview
1.39% Insiders
35.19% Mutual Funds
22.29% Other Institutional Investors
26.31% ETFs
14.83% Public Companies and
Individual Investors
The ownership structure of Haemonetics (HAE) stock is a mix of institutional, retail, and individual investors. Approximately 83.79% of the company’s stock is owned by Institutional Investors, 1.39% is owned by Insiders, and 14.83% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Nov 12, 2025 | xxxxxxxxxxxxx | $98784 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $5728721 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,193,703 | Institution | 11.18% | 309,129,203 | |
| 4,210,780 | Institution | 9.06% | 250,625,626 | |
| 3,627,137 | Institution | 7.81% | 215,887,194 | |
| 2,090,029 | Institution | 4.50% | 124,398,526 | |
| 950,260 | Institution | 2.04% | 56,559,475 | |
| 934,741 | Institution | 2.01% | 55,635,784 | |
| 861,263 | Institution | 1.85% | 51,262,374 | |
| 662,504 | Institution | 1.43% | 39,432,238 | |
| 636,613 | Institution | 1.37% | 37,891,206 | |
| 604,115 | Institution | 1.30% | 35,956,925 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 3,627,137 | Institution | 7.81% | 215,887,194 | |
| 2,090,029 | Institution | 4.50% | 124,398,526 | |
| 950,260 | Institution | 2.04% | 56,559,475 | |
| 861,263 | Institution | 1.85% | 51,262,374 | |
| 636,613 | Institution | 1.37% | 37,891,206 | |
| 604,115 | Institution | 1.30% | 35,956,925 | |
| 592,000 | Institution | 1.27% | 35,235,840 | |
| 544,170 | Institution | 1.17% | 32,388,998 | |
| 525,896 | Institution | 1.13% | 31,301,330 | |
| 523,718 | Institution | 1.13% | 31,171,695 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,567,099 | Institution | 3.37% | 121,152,424 | |
| 1,516,631 | Institution | 3.26% | 90,269,877 | |
| 1,478,764 | Institution | 3.18% | 93,635,336 | |
| 1,205,889 | Institution | 2.59% | 71,774,513 | |
| 1,062,563 | Institution | 2.29% | 67,281,489 | |
| 590,904 | Institution | 1.27% | 37,416,041 | |
| 510,394 | Institution | 1.10% | 32,318,148 | |
| 405,860 | Institution | 0.87% | 24,156,787 | |
| 343,166 | Institution | 0.74% | 20,425,240 | |
| 238,854 | Institution | 0.51% | 15,124,235 |
FAQ
Who Owns Haemonetics (HAE)?
According to the latest TipRanks data, approximately 22.29% of the company's stock is held by institutional investors, 1.39% is held by insiders, and 14.83% is held by retail investors.
What percentage of Haemonetics (HAE) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.29% of Haemonetics (HAE) stock is held by institutional investors.
What percentage of Haemonetics (HAE) stock is held by retail investors?
According to the latest TipRanks data, approximately 14.83% of Haemonetics (HAE) stock is held by retail investors.
Who owns the most shares of Haemonetics (HAE)?
iShares owns the most shares of Haemonetics (HAE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.